What does an Alanine Transaminase (ALT) level of 32 with normal Aspartate Transaminase (AST) indicate?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 19, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Understanding ALT 32 with Normal AST

An ALT of 32 U/L with normal AST is within normal limits for most adults and does not indicate liver injury. This pattern requires no intervention unless other clinical factors suggest liver disease.

Normal Reference Ranges and Clinical Context

  • Normal ALT levels are 29-33 IU/L in men and 19-25 IU/L in women, making an ALT of 32 U/L at the upper end of normal for men and mildly elevated for women 1.

  • ALT is the most liver-specific enzyme because it has minimal presence in cardiac muscle, skeletal muscle, kidneys, and red blood cells, unlike AST which is found in all these tissues 1, 2, 3.

  • AST is less specific for liver injury and can be elevated in cardiac disorders, skeletal muscle injury from exercise, kidney disease, and red blood cell disorders 1.

Clinical Significance of This Pattern

  • An AST/ALT ratio <1 (normal AST with ALT at 32) is the typical pattern seen in early or mild hepatocellular conditions like nonalcoholic fatty liver disease (NAFLD), viral hepatitis, or medication-induced liver injury 1.

  • However, ALT of 32 U/L does not meet criteria for hepatocellular injury, which requires ALT ≥5× upper limit of normal (≥165 U/L for men, ≥125 U/L for women) to warrant close observation 4.

  • This level does not trigger any monitoring algorithms outlined in consensus guidelines for drug-induced liver injury or chronic liver disease 4.

When to Consider Further Evaluation

  • If the patient is female, an ALT of 32 U/L represents mild elevation (upper limit 25 IU/L), which may warrant repeat testing in 2-4 weeks if there are risk factors for liver disease 1.

  • Assess for metabolic syndrome components (obesity, diabetes, hypertension) as risk factors for NAFLD, detailed alcohol consumption history, and complete medication review including over-the-counter drugs and supplements 1.

  • Repeat liver enzymes in 2-4 weeks only if clinical suspicion exists based on symptoms (fatigue, jaundice, pruritus, right upper quadrant pain) or risk factors 1.

Important Clinical Pitfalls

  • Do not assume normal ALT completely excludes liver disease, as some patients with significant liver pathology may have normal ALT levels, particularly in chronic hepatitis C where ALT can be normal despite active disease 2, 5.

  • AST may remain elevated when ALT is normal in certain conditions, suggesting that measuring both enzymes provides complementary information 5.

  • An AST/ALT ratio ≥1 typically indicates more advanced liver disease (alcoholic liver disease or cirrhosis), but when both are normal or near-normal, this ratio has limited clinical significance 6, 7.

References

Guideline

Evaluation and Management of Mildly Elevated Transaminases

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Elevated Alanine Transaminase (ALT): Indication and Clinical Significance

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

[Liver disorders in adults: ALT and AST].

Nederlands tijdschrift voor geneeskunde, 2013

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

An assessment of the clinical utility of serum ALT and AST in chronic hepatitis C.

Hepatology research : the official journal of the Japan Society of Hepatology, 2000

Research

The AST/ALT ratio as an indicator of cirrhosis in patients with PBC.

Liver international : official journal of the International Association for the Study of the Liver, 2006

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.